This review highlights the mechanistic role of obesity and metabolic abnormalities in driving the epidemic of cardiorenal metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
May warrant addressing obesity in cardiorenal patients; extends mechanistic insights but leaves optimal interventions open.
Sowers et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: